These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 15389988)

  • 21. Long-term treatment with botulinum toxin type A in cervical dystonia has low immunogenicity by mouse protection assay.
    Brin MF; Comella CL; Jankovic J; Lai F; Naumann M;
    Mov Disord; 2008 Jul; 23(10):1353-60. PubMed ID: 18546321
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Botulinum toxin treatment of hip adductor spasticity in multiple sclerosis].
    Wissel J; Entner T
    Wien Klin Wochenschr; 2001; 113 Suppl 4():20-4. PubMed ID: 15506048
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Effects of treatment of spasmodic torticollis by neurovascular decompression, myotomy, and toxin type A: a comparative study].
    Sun KH; Lu YC; Hu GH; Luo C; Hou LJ; Chen JX; Zhou J
    Zhonghua Yi Xue Za Zhi; 2009 Jan; 89(1):21-4. PubMed ID: 19489238
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cervical dystonia: a review the role of botulinum toxin.
    Edwards LL; Normand MM; Wszolek ZK
    Nebr Med J; 1995 May; 80(5):109-15. PubMed ID: 7791942
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fatal case of BOTOX-related anaphylaxis?
    Li M; Goldberger BA; Hopkins C
    J Forensic Sci; 2005 Jan; 50(1):169-72. PubMed ID: 15831014
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Botulinum toxin and neuromotor rehabilitation: An integrated approach to idiopathic cervical dystonia.
    Tassorelli C; Mancini F; Balloni L; Pacchetti C; Sandrini G; Nappi G; Martignoni E
    Mov Disord; 2006 Dec; 21(12):2240-3. PubMed ID: 17029278
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term clinical outcome after botulinum toxin injection in children with nonrelaxing internal anal sphincter.
    Chumpitazi BP; Fishman SJ; Nurko S
    Am J Gastroenterol; 2009 Apr; 104(4):976-83. PubMed ID: 19259081
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Therapeutic outcome of spasmodic torticollis].
    Hasegawa O; Matsumoto S; Gondo G; Arita T; Iwasawa H
    No To Shinkei; 2001 Jun; 53(6):547-50. PubMed ID: 11436339
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anterior and posterior sagittal shift in cervical dystonia: a clinical and electromyographic study, including a new EMG approach of the longus colli muscle.
    Flowers JM; Hicklin LA; Marion MH
    Mov Disord; 2011 Nov; 26(13):2409-14. PubMed ID: 21913223
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cervical radiculopathy following botulinum toxin therapy for cervical dystonia.
    Defazio G; Lepore V; Melpignano C; Lamberti P; Livrea P; Ferrari E
    Funct Neurol; 1993; 8(3):193-6. PubMed ID: 8406138
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy and safety of botulinum type A toxin (Dysport) in cervical dystonia: results of the first US randomized, double-blind, placebo-controlled study.
    Truong D; Duane DD; Jankovic J; Singer C; Seeberger LC; Comella CL; Lew MF; Rodnitzky RL; Danisi FO; Sutton JP; Charles PD; Hauser RA; Sheean GL
    Mov Disord; 2005 Jul; 20(7):783-91. PubMed ID: 15736159
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment of severe achalasia during pregnancy with esophagoscopic injection of botulinum toxin A: a case report.
    Wataganara T; Leelakusolvong S; Sunsaneevithayakul P; Vantanasiri C
    J Perinatol; 2009 Sep; 29(9):637-9. PubMed ID: 19710656
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reverse sensory geste in cervical dystonia.
    Asmus F; von Coelln R; Boertlein A; Gasser T; Mueller J
    Mov Disord; 2009 Jan; 24(2):297-300. PubMed ID: 19086084
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Botulinum toxin injection for congenital muscular torticollis presenting in children and adults.
    Collins A; Jankovic J
    Neurology; 2006 Sep; 67(6):1083-5. PubMed ID: 17000985
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quantitative measurement of cervical range of motion in patients with torticollis treated with botulinum A toxin.
    Dykstra D; Ellingham C; Belfie A; Baxter T; Lee M; Voelker A
    Mov Disord; 1993; 8(1):38-42. PubMed ID: 8419806
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Idiosyncratic adverse reactions to intramuscular botulinum toxin type A injection.
    LeWitt PA; Trosch RM
    Mov Disord; 1997 Nov; 12(6):1064-7. PubMed ID: 9399239
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of botulinum toxin type A in the radiation fibrosis syndrome: a preliminary report.
    Stubblefield MD; Levine A; Custodio CM; Fitzpatrick T
    Arch Phys Med Rehabil; 2008 Mar; 89(3):417-21. PubMed ID: 18295617
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Aspects of the complexity of cervical dystonia].
    Hefter H
    Nervenarzt; 2008 Jun; 79 Suppl 1():15-8. PubMed ID: 18927959
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Smothering dystonia in a patient with oromandibular dystonia.
    Grill S
    Mov Disord; 2004 Nov; 19(11):1374-5. PubMed ID: 15389989
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CDIP-58 can measure the impact of botulinum toxin treatment in cervical dystonia.
    Cano SJ; Hobart JC; Edwards M; Fitzpatrick R; Bhatia K; Thompson AJ; Warner TT
    Neurology; 2006 Dec; 67(12):2230-2. PubMed ID: 17190951
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.